Literature DB >> 19844105

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

Fredrik Boström1, Oskar Hansson, Kaj Blennow, Lars Gerhardsson, Thomas Lundh, Lennart Minthon, Henrik Zetterberg, Elisabet Londos.   

Abstract

A pathology typical of dementia with Lewy bodies (DLB) has been demonstrated to increase mortality to a greater extent than the pathology of Alzheimer's disease (AD). However, mortality in DLB has also been shown to increase with concomitant AD pathology. Furthermore, in a recent publication, we showed that there is a robust and specific increase in CSF calcium and magnesium in DLB patients compared to both AD patients and controls. Thus, in order to explore the influence of CSF AD markers and trace element concentrations on mortality in DLB, we undertook a longitudinal prospective study of 47 clinically diagnosed DLB patients and 157 AD patients as well as 49 healthy volunteers. Both AD and DLB patients showed an increased mortality compared to the healthy controls (relative risk: 10 and 8, respectively; p < 0.001). Increased levels of CSF total tau were associated with increased mortality among the DLB patients (p < 0.05), but not among the AD patients or controls. Gender, age, MMSE score, Abeta42 concentration and phosphorylated tau, and CSF trace element concentrations did not influence survival in the obtained models. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844105     DOI: 10.1159/000249145

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  11 in total

1.  Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.

Authors:  Milica G Kramberger; Bjørn Auestad; Sara Garcia-Ptacek; Carla Abdelnour; Josep Garre Olmo; Zuzana Walker; Afina W Lemstra; Elisabet Londos; Frederic Blanc; Laura Bonanni; Ian McKeith; Bengt Winblad; Frank Jan de Jong; Flavio Nobili; Elka Stefanova; Maria Petrova; Cristian Falup-Pecurariu; Irena Rektorova; Sevasti Bostantjopoulou; Roberta Biundo; Daniel Weintraub; Dag Aarsland
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

Authors:  Henrik Zetterberg; Niklas Mattsson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-14

3.  The Pentagon Copying Test and the Clock Drawing Test as Prognostic Markers in Dementia with Lewy Bodies.

Authors:  Leonie J M Vergouw; Mariet Salomé; Anke G Kerklaan; Christiaan Kies; Gerwin Roks; Esther van den Berg; Frank Jan de Jong
Journal:  Dement Geriatr Cogn Disord       Date:  2018-07-11       Impact factor: 2.959

4.  Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives.

Authors:  Elisabet Londos
Journal:  Neurol Ther       Date:  2017-12-19

5.  Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  Victoria Larsson; Gustav Torisson; Elisabet Londos
Journal:  PLoS One       Date:  2018-08-10       Impact factor: 3.240

Review 6.  Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review.

Authors:  Amir Abbas Tahami Monfared; Genevieve Meier; Richard Perry; Darren Joe
Journal:  Neurol Ther       Date:  2019-09-12

7.  β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies.

Authors:  Daniel Ferreira; Scott A Przybelski; Timothy G Lesnick; Afina W Lemstra; Elisabet Londos; Frederic Blanc; Zuzana Nedelska; Christopher G Schwarz; Jonathan Graff-Radford; Matthew L Senjem; Julie A Fields; David S Knopman; Rodolfo Savica; Tanis J Ferman; Neill R Graff-Radford; Val J Lowe; Clifford R Jack; Ronald C Petersen; Brit Mollenhauer; Sara Garcia-Ptacek; Carla Abdelnour; Jakub Hort; Laura Bonanni; Ketil Oppedal; Milica G Kramberger; Bradley F Boeve; Dag Aarsland; Eric Westman; Kejal Kantarci
Journal:  Neurology       Date:  2020-09-28       Impact factor: 9.910

8.  The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.

Authors:  Kajsa Stubendorff; Dag Aarsland; Lennart Minthon; Elisabet Londos
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

9.  Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.

Authors:  Kajsa Stubendorff; Victoria Larsson; Clive Ballard; Lennart Minthon; Dag Aarsland; Elisabet Londos
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692

10.  High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease.

Authors:  Malin Degerman Gunnarsson; Martin Ingelsson; Kaj Blennow; Hans Basun; Lars Lannfelt; Lena Kilander
Journal:  Alzheimers Res Ther       Date:  2016-06-06       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.